Eureka!
Eureka!
McKinsey colleagues Alex Devereson and Nav Nagra explore cutting-edge technology trends, tackle pressing industry challenges, and uncover R&D innovations with biopharma leaders. Whether you're a seasoned professional or a curious enthusiast, this series offers valuable insights and thought-provoking discussions that will keep you informed and inspired. Tune in and stay ahead of the curve in the ev…
Pfizer’s Alex Condoleon on medical affairs accountability
Pfizer’s chief medical affairs officer talks about measuring medical affairs’ true impact, leading change at scale, and what patient-first really means.
46:52
Novartis’s Christian Diehl on scaling AI beyond the demo
Novartis’s chief data and digital officer for biomedical research explains how data platform investments are paying off in AI safety prediction, generative chemistry, and faster translation
42:24
AstraZeneca's Bob Li on the MARS mission to eliminate cancer
Bob Li, AstraZeneca's Senior Vice President, Global Head of Medical Affairs, Oncology, on why only seven percent of cancer patients get access to clinical trials, and what decentralized trials, AI, and international collaboration could do to change that within a decade.
37:40
McKinsey’s Fangning Zhang on China’s growing role in life sciences R&D
McKinsey partner Fangning Zhang discusses what’s driving China’s acceleration in drug discovery, why intense competition is fueling speed and cost efficiency, and what global R&D leaders need to do to build a genuine China strategy.
28:07
Bayer’s Sai Jasti on driving productivity in R&D with data science and AI
Bayer’s Senior Vice President and Head of Data Science and AI, Sai Jasti, on how the company is transforming its workflows and embedding AI in research and development to meet ambitious productivity goals.
30:35
Bristol Myers Squibb CDTO Greg Meyers on biopharma’s AI-enabled future
Greg Meyers, Executive Vice President and Chief Digital & Technology Officer at Bristol Myers Squibb (BMS) discusses how technology can be leveraged to drive outcomes.
30:08
Lykke Hinsch Gylvin on the cutting edge of clinical trial design
Lykke Hinsch Gylvin shares how Boehringer Ingelheim’s innovative clinical trial designs bring therapies to patients faster.
23:48
Genentech’s John Marioni on enhancing drug discovery with data and AI
John Marioni discusses how he and his teams across industries and academia use evolving technologies to bring sophisticated drug therapies to patients.
32:03
J&J’s Ashita Batavia on advancing oncology clinical-trials with data
In this episode of Eureka!, a McKinsey podcast on innovation in life sciences R&D, hosts Navraj Nagra, Alex Devereson, and Meredith Langstaff speak to Ashita Batavia, head of hematology and oncology data sciences, R&D, at Johnson & Johnson Innovative Medicine (J&J). They discuss how real-world data…
32:21
GSK's Kim Branson on driving innovation with AI and machine learning
In this episode, hosts Navraj Nagra and Alex Devereson speak to Kim Branson, senior vice president and global head of AI and machine learning at GSK. They discuss how these emerging technologies are being used to potentially reshape how drugs are developed and about the complexities AI and machine …
27:07